Results 161 to 170 of about 44,418 (298)
Diabetes/Metabolism Research and Reviews, Volume 42, Issue 4, May 2026.ABSTRACT Aims Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are widely used for metabolic disorders, but emerging safety concerns include alopecia and reproductive or endocrine‐related adverse events (AEs). This study investigated the association between specific GLP‐1 RAs and these endocrine‐related AEs using a large‐scale pharmacovigilance ...
Nai Lee, Yun Kim
wiley +1 more source
Haemoglobin A1c Time‐In‐Range and Mortality in Adults With Diabetes
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.Reduced A1c time in range and particularly greater time below range are associated with increased mortality in adults with diabetes. A1c stability within person‐specific ranges may be a risk predictor for major outcomes in adults with diabetes. ABSTRACT Introduction Glycemic variability over time is a risk factor for diabetes complications.
Paul R. Conlin +8 more
wiley +1 more source
Monitoring of sulfonylurea herbicides in stream water draining intensively cultivated areas in southern Sweden during a 9-year period (1998-2006) [PDF]
, 2008 Jenny Kreuger, Stina Adielsson
openalex
GLP‐1 at the Metabolic–Cognitive Interface: Reward, Affect, and Memory
Comprehensive Physiology, Volume 16, Issue 2, April 2026.GLP‐1R signaling integrates metabolic state with neural circuits controlling reward, mood, and memory, acting as a metabolic‐cognitive interface. In reward pathways, it suppresses hedonic feeding and drug seeking; in affective circuits, sustained signaling promotes anxiolytic and antidepressant effects; and in the hippocampus, it enhances synaptic ...
Serena X. Gao +5 more
wiley +1 more source
Comparison of decision tree with common machine learning models for prediction of biguanide and sulfonylurea poisoning in the United States: an analysis of the National Poison Data System [PDF]
, 2023 Omid Mehrpour +6 more
openalex +1 more source
European Journal of Sport Science, Volume 26, Issue 4, April 2026.ABSTRACT To examine the acute effect of gliclazide on exercise performance and recovery of muscle strength in healthy participants. We conducted a randomized, double‐blind, placebo‐controlled crossover clinical trial in 44 strength‐trained men. They were allocated to gliclazide modified release (MR) (90 mg, 8h before exercise sessions) or placebo ...
Jocelito Bijoldo Martins +3 more
wiley +1 more source
Neonatal Diabetes Caused by Mutations in Sulfonylurea Receptor 1: Interplay between Expression and Mg-Nucleotide Gating Defects of ATP-Sensitive Potassium Channels [PDF]
, 2010 Qing Zhou +6 more
openalex +1 more source
Food Science &Nutrition, Volume 14, Issue 4, April 2026.This study examines the potential of phytochemicals from native Pakistani plants to mitigate the effects of diabetes by interacting with GLP‐1R and SGLT2 proteins using bioinformatics methods, thereby highlighting the application of bioinformatics in this context.
Malaika Ajaz +9 more
wiley +1 more source
Characteristics of sulfonylurea-resistant Scirpus juncoides emerged in Fukuoka
, 2004 Hideki Ohdan, T. Sumiyoshi, Akira Koarai
openalex +2 more sources
Obesity Science &Practice, Volume 12, Issue 2, April 2026.ABSTRACT Introduction Information on therapeutic inertia (TI) in weight loss in people with type 2 diabetes (T2D) is limited. Objective To describe the prevalence of TI in the management of overweight/obesity in people with T2D undergoing primary care program (PCP) follow‐up and weight changes according to the prescribed treatment.
Pablo Aschner, Diana Henao‐Carrillo
wiley +1 more source